{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:22:59Z","timestamp":1791606179721,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T00:00:00Z","timestamp":1619308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T00:00:00Z","timestamp":1619308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11030-021-10224-4","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T14:02:15Z","timestamp":1619359335000},"page":"341-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["In vitro antimicrobial evaluation and in silico studies of coumarin derivatives tagged with pyrano-pyridine and pyrano-pyrimidine moieties as DNA gyrase inhibitors"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4579-5180","authenticated-orcid":false,"given":"Eman A.","family":"Fayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman S.","family":"Nosseir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Atef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar A.","family":"El\u2011Kalyoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,25]]},"reference":[{"key":"10224_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1054-3589(08)60547-5","volume-title":"DNA topoisomerases: biochemistry and molecular biology","author":"WM Huang","year":"1994","unstructured":"Huang WM (1994) Type II DNA topoisomerase genes. In: August JT, Anders MW, Murad F, Coyle JT, Liu L (eds) DNA topoisomerases: biochemistry and molecular biology, vol 29. Academic Press, London, pp 201\u2013225"},{"key":"10224_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00253-012-4609-8","volume":"97","author":"RJ Scheffler","year":"2013","unstructured":"Scheffler RJ, Colmer S, Tyman H, Demain AL, Gullo VP (2013) Antimicrobials, drug discovery and genome mining. Appl Microbiol Biotechnol 97:969\u2013978. https:\/\/doi.org\/10.1007\/s00253-012-4609-8","journal-title":"Appl Microbiol Biotechnol"},{"key":"10224_CR3","doi-asserted-by":"publisher","first-page":"14252","DOI":"10.1074\/jbc.M500156200","volume":"280","author":"E Leo","year":"2005","unstructured":"Leo E, Gould KA, Su Pan X, Capranico G, Sanderson MR, Palumbo M, Fisher LM (2005) Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site. J Biolog Chem 280:14252\u201314263","journal-title":"J Biolog Chem"},{"key":"10224_CR4","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1128\/AAC.48.5.1856-1864.2004","volume":"48","author":"S Bellon","year":"2004","unstructured":"Bellon S, Parsons JD, Wei Y, Hayakawa K, Swenson LL, Charifson PS, Lippke JA, Aldape R, Gross CH (2004) Crystal structures of Escherichia coli topoisomerase IV ParE Subunit (24 and 43 Kilodaltons): a Single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase. Antimicrob Agents Chemother 48:1856\u20131864. https:\/\/doi.org\/10.1128\/AAC.48.5.1856-1864.2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10224_CR5","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/jac\/dkr247","volume":"66","author":"S Alt","year":"2011","unstructured":"Alt S, Mitchenall LA, Maxwell A, Heide L (2011) Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. J Antimicrob Chemother 66(9):2061\u20132069. https:\/\/doi.org\/10.1093\/jac\/dkr247","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10224_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","volume":"70","author":"JJ Champoux","year":"2001","unstructured":"Champoux JJ (2001) DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 70(1):369\u2013413. https:\/\/doi.org\/10.1146\/annurev.biochem.70.1.369","journal-title":"Annu Rev Biochem"},{"key":"10224_CR7","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1093\/nar\/gkz260","volume":"47","author":"DR Reus","year":"2019","unstructured":"Reus DR, Fashauer P, Mroch PJ, Ul-Haq I, Mo Koo B, Pohlein A, Gross CA, Daniel R, Brantl S, Stulke J (2019) Topoisomerase IV can functionally replace all type 1A topoisomerases in Bacillus subtilis. Nucl Acids Res 47:5231\u20135242. https:\/\/doi.org\/10.1093\/nar\/gkz260","journal-title":"Nucl Acids Res"},{"issue":"7","key":"10224_CR8","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/1871520613666131224124445","volume":"14","author":"V Jamier","year":"2014","unstructured":"Jamier V, Marut W, Valente S, Chereau C, Chouzenoux S, Nicco C, Lemarechal H, Weill B, Kirsch G, Jacob C, Batteux F (2014) Chalcone-coumarin derivatives as potential anti-cancer drugs: an in vitro and in vivo investigation. Anticancer Agents Med Chem 14(7):963\u2013974. https:\/\/doi.org\/10.2174\/1871520613666131224124445","journal-title":"Anticancer Agents Med Chem"},{"issue":"3","key":"10224_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2174\/1871520616666160902094739","volume":"17","author":"V Thomas","year":"2017","unstructured":"Thomas V, Giles D, Basavarajaswamy GPM, Patel A (2017) Coumarin derivatives as anti-inflammatory and anticancer agents. Anticancer Agents Med Chem 17(3):415\u2013423. https:\/\/doi.org\/10.2174\/1871520616666160902094739","journal-title":"Anticancer Agents Med Chem"},{"key":"10224_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.arabjc.2012.12.041","volume":"7","author":"ER El-Sawy","year":"2014","unstructured":"El-Sawy ER, Ebaid MS, Abo-Salem HM, Al-Sehemi AG, Mandour AH (2014) Synthesis, anti-inflammatory, analgesic and anticonvulsant activities of some new 4,6-dimethoxy-5-(heterocycles)benzofuran starting from naturally occurring visnagin. Arabian J Chem 7:914\u2013923. https:\/\/doi.org\/10.1016\/j.arabjc.2012.12.041","journal-title":"Arabian J Chem"},{"key":"10224_CR11","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.3390\/ijms12095747","volume":"12","author":"AAH Kadhum","year":"2011","unstructured":"Kadhum AAH, Al-Amiery AA, Musa AY, Mohamad AB (2011) The antioxidant activity of new coumarin derivatives. Int J Mol Sci 12:5747\u20135761. https:\/\/doi.org\/10.3390\/ijms12095747","journal-title":"Int J Mol Sci"},{"key":"10224_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5402\/2012\/707932","volume":"2012","author":"A Raza","year":"2012","unstructured":"Raza A, Saeed A, Ibrar A, Muddassar M, Khan AA, Iqbal J (2012) Pharmacological evaluation and docking studies of 3-thiadiazolyl- and thioxo-1,2,4-triazolylcoumarin derivatives as cholinesterase inhibitors. Int Schol Res Netw ISRN Pharmacol 2012:11. https:\/\/doi.org\/10.5402\/2012\/707932","journal-title":"Int Schol Res Netw ISRN Pharmacol"},{"issue":"10","key":"10224_CR13","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1021\/np070295v","volume":"70","author":"P Curir","year":"2007","unstructured":"Curir P, Galeotti F, Dolci M, Barile E, Lanzotti V (2007) Pavietin, a coumarin from aesculus pavia with antifungal activity. J Nat Prod 70(10):1668\u20131671. https:\/\/doi.org\/10.1021\/np070295v","journal-title":"J Nat Prod"},{"key":"10224_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1099\/ijs.0.02008-0","volume":"52","author":"B Lanoot","year":"2002","unstructured":"Lanoot B, Vancanneyt M, Cleenwerck I, Wang L, Li W, Liu Z, Swings J (2002) The search for synonyms among streptomycetes by using SDS-PAGE of wholecell proteins. Emendation of the species Streptomyces aurantiacus, Streptomyces cacaoi subsp. cacaoi, Streptomyces caeruleus and Streptomyces violaceus. Int J Syst Evol Microbiol 52:823\u2013829. https:\/\/doi.org\/10.1099\/ijs.0.02008-0","journal-title":"Int J Syst Evol Microbiol"},{"key":"10224_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ja.2017.70","volume":"70","author":"LR Singh","year":"2017","unstructured":"Singh LR, Avula SR, Raj S, Srivastava A, Palnati GR, Tripathi CKM, Pasupuleti M, Sashidhara KV (2017) Coumarin\u2013benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation. J Antibiot 70:1\u20138. https:\/\/doi.org\/10.1038\/ja.2017.70","journal-title":"J Antibiot"},{"issue":"3","key":"10224_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1128\/AAC.47.3.869-877.2003","volume":"47","author":"E Schmutz","year":"2003","unstructured":"Schmutz E, M\u00fchlenweg A, Li SM, Heide L (2003) Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin a1 and clorobiocin. Antimicrob Agents Chemother 47(3):869\u2013877. https:\/\/doi.org\/10.1128\/AAC.47.3.869-877.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10224_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0092-8674(79)90305-2","volume":"17","author":"A Morrison","year":"1979","unstructured":"Morrison A, Cozzarelli NR (1979) Site-specific cleavage of DNA by E. coli DNA gyrase. Cell 17(1):175\u2013184. https:\/\/doi.org\/10.1016\/0092-8674(79)90305-2","journal-title":"Cell"},{"key":"10224_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bioorg.2017.01.019","volume":"71","author":"V Singh","year":"2017","unstructured":"Singh V, Katiyar D (2017) Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols. Bioorg. Chem. 71:120\u2013127. https:\/\/doi.org\/10.1016\/j.bioorg.2017.01.019","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10224_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.bmc.2017.01.001","volume":"25","author":"NS Naik","year":"2017","unstructured":"Naik NS, Shastri LA, Joshi SD, Dixit SR, Chougala BM, Samundeeswari S, Holiyachi M, Shaikh F, Madar J, Kulkarni R, Sunagar V (2017) 3,4-Dihydropyrimidinone-coumarin analogues as a new class of selective agent against S. aureus: synthesis, biological evaluation and molecular modelling study. Bioorg Med Chem 25(4):1413\u20131422. https:\/\/doi.org\/10.1016\/j.bmc.2017.01.001","journal-title":"Bioorg Med Chem"},{"key":"10224_CR20","doi-asserted-by":"publisher","first-page":"103672","DOI":"10.1016\/j.bioorg.2020.103672","volume":"97","author":"NH Metwally","year":"2020","unstructured":"Metwally NH, Abdallah SO, Mohsen MMA (2020) Design, green one-pot synthesis and molecular docking study of novel N, N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV. Bioorg Chem 97:103672. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103672","journal-title":"Bioorg Chem"},{"key":"10224_CR21","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.ejmech.2017.10.046","volume":"143","author":"MF El Shehry","year":"2018","unstructured":"El Shehry MF, Ghorab MM, Abbas SY, Fayed EA, Shedid SA, Ammar YA (2018) Quinoline derivatives bearing pyrazole moiety: synthesis and biological evaluation as possible antibacterial and antifungal agents. Eur J Med Chem 143:1463\u20131473. https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.046","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10224_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-017-0294-0","volume":"11","author":"SA El-Kalyoubi","year":"2017","unstructured":"El-Kalyoubi SA, Fayed EA, Abdel-Razek AS (2017) One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines. Chem Cent J 11(1):1\u201313. https:\/\/doi.org\/10.1186\/s13065-017-0294-0","journal-title":"Chem Cent J"},{"key":"10224_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/00397911.2017.1328066","author":"YA Ammar","year":"2017","unstructured":"Ammar YA, Salem MA, Fayed EA, Helal MH, El-Gaby MSA, Thabet HK (2017) Naproxen derivatives: synthesis, reactions, and biological applications. Synth Commun. https:\/\/doi.org\/10.1080\/00397911.2017.1328066","journal-title":"Synth Commun"},{"issue":"8","key":"10224_CR24","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00044-019-02373-x","volume":"28","author":"EA Fayed","year":"2019","unstructured":"Fayed EA, Sabour R, Harras MF, Mehany ABM (2019) Design, synthesis, biological evaluation and molecular modeling of new coumarin derivatives as potent anticancer agents. Med Chem Res 28(8):1284\u20131297. https:\/\/doi.org\/10.1007\/s00044-019-02373-x","journal-title":"Med Chem Res"},{"issue":"12","key":"10224_CR25","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.3184\/174751916X14798125870610","volume":"40","author":"S Elkalyoubi","year":"2016","unstructured":"Elkalyoubi S, Fayed E (2016) Synthesis and evaluation of antitumour activities of novel fused tri-And tetracyclic uracil derivatives. J Chem Res 40(12):2016. https:\/\/doi.org\/10.3184\/174751916X14798125870610","journal-title":"J Chem Res"},{"key":"10224_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103841","author":"YA Ammar","year":"2020","unstructured":"Ammar YA, Farag AA, Ali AM, Hessein SA, Askar AA, Fayed EA, Elsisi DM, Ragab A (2020) Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies. Bioorgan Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103841","journal-title":"Bioorgan Chem"},{"issue":"1","key":"10224_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11030-018-9865-9","volume":"23","author":"EA Fayed","year":"2019","unstructured":"Fayed EA, Eissa SI, Bayoumi AH, Gohar NA, Mehany ABM, Ammar YA (2019) Design, synthesis, cytotoxicity and molecular modeling studies of some novel fluorinated pyrazole-based heterocycles as anticancer and apoptosis-inducing agents. Mol Diver 23(1):165\u2013181. https:\/\/doi.org\/10.1007\/s11030-018-9865-9","journal-title":"Mol Diver"},{"key":"10224_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11164-017-3019-z","author":"YA Ammar","year":"2017","unstructured":"Ammar YA, Fayed EA, Bayoumi AH (2017) New chalcones bearing isatin scaffold: synthesis, molecular modeling and biological evaluation as anticancer agents. Res Chem Intermed. https:\/\/doi.org\/10.1007\/s11164-017-3019-z","journal-title":"Res Chem Intermed"},{"key":"10224_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103951","author":"EA Fayed","year":"2020","unstructured":"Fayed EA, Ammar YA, Ragab A, Gohar NA, Mehany ABM, Farrag AM (2020) In vitro cytotoxic activity of thiazole-indenoquinoxaline hybrids as apoptotic agents, design, synthesis, physicochemical and pharmacokinetic studies. Bioorgan Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103951","journal-title":"Bioorgan Chem"},{"key":"10224_CR30","first-page":"245","volume":"5","author":"YA Ammar","year":"2015","unstructured":"Ammar YA, Fayed EA, Bayoumi AH, Saleh MA, El-Araby ME (2015) Design and synthesis of pyridine-amide based compounds appended naproxen moiety as anti-microbial and anti-inflammatory agents. Am J PharmTech Res 5:245\u201373","journal-title":"Am J PharmTech Res"},{"key":"10224_CR31","unstructured":"Mousa BA, Khalifa MM, Fayed EA, Said MM, Ahmed HI (2017) Synthesis, anxiolytic and tranquilizing activity of some new 1, 4-diazepine derivatives. Am J PharmTech Res 7(2), 2017. http:\/\/www.ajptr.com\/."},{"issue":"13","key":"10224_CR32","first-page":"77","volume":"8","author":"EA Fayed","year":"2016","unstructured":"Fayed EA, Ahmed HY (2016) Synthesis, characterization and pharmacological evaluation of some new 1,4-diazepine derivatives as anticancer agents. Der Pharma Chemica 8(13):77\u201390","journal-title":"Der Pharma Chemica"},{"issue":"1","key":"10224_CR33","first-page":"495","volume":"8","author":"YA Ammar","year":"2016","unstructured":"Ammar YA, Fayed EA, Bayoumi AH, Saleh MA (2016) Synthesis and biological evaluation of new amides pro-drugs containing naproxen moiety as anti-inflammatory and antimicrobial agents. Der Pharma Chemica 8(1):495\u2013508","journal-title":"Der Pharma Chemica"},{"issue":"4","key":"10224_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/157018011794839448","volume":"8","author":"BA AbdelFattah","year":"2011","unstructured":"AbdelFattah BA, Khalifa MMA, El-Sehrawi H, Fayed E, Bayoumi A (2011) Synthesis and anxiolytic activity of some novel 5-oxo-1, 4-oxazepine derivatives. Lett Drug Des Discov 8(4):330\u2013338. https:\/\/doi.org\/10.2174\/157018011794839448","journal-title":"Lett Drug Des Discov"},{"key":"10224_CR35","first-page":"189","volume":"9","author":"GM El-Sherbiny","year":"2017","unstructured":"El-Sherbiny GM, Ai E, Im E, Askar AA (2017) Antibacterial potential with molecular docking study against multi-drug resistant bacteria and mycobacterium tuberculosis of streptomycin produced by streptomyces atroverins, strain askar-SH50A, antibacterial potential with molecular. J Chem Pharm Res 9:189\u2013208","journal-title":"J Chem Pharm Res"},{"key":"10224_CR36","volume-title":"Microbiology, laboratory manual","author":"JCN Sherman","year":"2004","unstructured":"Sherman JCN (2004) Microbiology, laboratory manual. Pearson Education, Inc., New Delhi"},{"key":"10224_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","volume":"45","author":"AW Baur","year":"1966","unstructured":"Baur AW, Kirby WM, Sherris JC, Truck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493\u2013496","journal-title":"Am J Clin Pathol"},{"key":"10224_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejmech.2018.09.053","volume":"159","author":"F Bi","year":"2018","unstructured":"Bi F, Song D, Zhang N, Liu Z, Gu X, Hu C, Cai X, Venter H, Ma S (2018) Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators. Eur J Med Chem 159:90\u2013103. https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.053","journal-title":"Eur J Med Chem"},{"key":"10224_CR39","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.bbrc.2019.05.086","volume":"514","author":"N Sun","year":"2019","unstructured":"Sun N, Li M, Cai S, Li Y, Chen C, Zheng Y, Li X, Fang Z, Lv H, Lu Y (2019) Biochemical and biophysical research communications antibacterial evaluation and mode of action study of bimq, a novel bacterial cell division inhibitor. Biochem Biophys Res Commun 514:1224\u20131230. https:\/\/doi.org\/10.1016\/j.bbrc.2019.05.086","journal-title":"Biochem Biophys Res Commun"},{"key":"10224_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122865","author":"F Al-Blewi","year":"2019","unstructured":"Al-Blewi F, Rezki N, Adjet A, Qutb Uddin H, Al-Sodies S, Messali M, Aouad MR, Bardaweel S (2019) A profile of the in vitro anti-tumor activity and in silico ADME predictions of novel benzothiazole amide-functionalized imidazolium ionic liquids. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20122865","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10224_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1PII of original article: S0169\u2013409X(96), 00423\u20131. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3\u201325.1. Adv Drug Deliv Rev 46(1):3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"issue":"21","key":"10224_CR42","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1021\/jp980230o","volume":"102","author":"AK Ghose","year":"1998","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ (1998) Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J Phys Chem A 102(21):3762\u20133772. https:\/\/doi.org\/10.1021\/jp980230o","journal-title":"J Phys Chem A"},{"issue":"12","key":"10224_CR43","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45(12):2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"issue":"3","key":"10224_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0169-409x(02)00004-2","volume":"54","author":"WJ Egan","year":"2002","unstructured":"Egan WJ, Lauri G (2002) Prediction of intestinal permeability. Adv Drug Deliv Rev 54(3):273\u2013289. https:\/\/doi.org\/10.1016\/s0169-409x(02)00004-2","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10224_CR45","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44(12):1841\u20131846. https:\/\/doi.org\/10.1021\/jm015507e","journal-title":"J Med Chem"},{"issue":"10","key":"10224_CR46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/antibiotics9100695","volume":"9","author":"EM Mohi El-Deen","year":"2020","unstructured":"Mohi El-Deen EM, Abd El-Meguid EA, Karam EA, Nossier ES, Ahmed MF (2020) Synthesis and biological evaluation of new pyridothienopyrimidine derivatives as antibacterial agents and escherichia coli topoisomerase II inhibitors. Antibiotics 9(10):695. https:\/\/doi.org\/10.3390\/antibiotics9100695","journal-title":"Antibiotics"},{"key":"10224_CR47","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1021\/bi0159837","volume":"41","author":"D Lafitte","year":"2002","unstructured":"Lafitte D, Lamour V, Tsvetkov PO, Makarov AA, Klich M, Deprez P, Moras D, Briand C, Gilli R (2002) DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5\u2019-methyl group of the noviose. Biochemistry 41:7217\u20137223. https:\/\/doi.org\/10.1021\/bi0159837","journal-title":"Biochemistry"},{"issue":"1","key":"10224_CR48","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1080\/14756366.2019.1637861","volume":"34","author":"IM Othman","year":"2019","unstructured":"Othman IM, Gad-Elkareem MA, El-Naggar M, Nossier ES, Amr AE (2019) Novel phthalimide based analogues: design, synthesis, biological evaluation, and molecular docking studies. J Enzyme Inhib Med Chem 34(1):1259\u20131270. https:\/\/doi.org\/10.1080\/14756366.2019.1637861","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10224_CR49","first-page":"161","volume":"66","author":"N Siddiqi","year":"2009","unstructured":"Siddiqi N, Arshad F, Khan S (2009) Synthesis of some new coumarin incorporated thiazolyl symicarbazones as anticonvulsants. Pharm Soci 66:161\u2013167","journal-title":"Pharm Soci"},{"issue":"5","key":"10224_CR50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijantimicag.2008.10.026","volume":"33","author":"AN Sudjana","year":"2009","unstructured":"Sudjana AN, D\u2019Orazio C, Ryan V, Rasool N, Ng J, Islam N, Riley TV, Hammer KA (2009) Antimicrobial activity of commercial Olea europaea (olive) leaf extract. Int J Antimicrob Agents 33(5):461\u2013463. https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.10.026","journal-title":"Int J Antimicrob Agents"},{"key":"10224_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biocontrol.2011.12.013","volume":"64","author":"G Sangeetha","year":"2013","unstructured":"Sangeetha G, Thangavelu R, Usha RS, Muthukumar A (2013) Antimicrobial activity of medicinal plants and induction of defense related compounds in banana fruits cv. Robusta against crown rot pathogens. Biol Control 64:16\u201325. https:\/\/doi.org\/10.1016\/j.biocontrol.2011.12.013","journal-title":"Biol Control"},{"key":"10224_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104803","author":"SI Eissa","year":"2021","unstructured":"Eissa SI, Farrag AM, Abbas SY, El Shehry MF, Ragab A, Fayed EA, Ammar YA (2021) Novel structural hybrids of quinoline and thiazole moieties: Synthesis and evaluation of antibacterial and antifungal activities with molecular modeling studies. Bioorgan Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104803","journal-title":"Bioorgan Chem"},{"key":"10224_CR53","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejmech.2016.11.042","volume":"126","author":"E Yahia","year":"2017","unstructured":"Yahia E, Mohammad H, Abdelghany TM, Seleem MN, Mayhoub AS (2017) Phenylthiazole antibiotics: a metabolism-guided approach to overcome short duration of action. Eur J Med Chem 126:604\u2013613. https:\/\/doi.org\/10.1016\/j.ejmech.2016.11.042","journal-title":"Eur J Med Chem"},{"key":"10224_CR54","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/jac\/dkr247","volume":"66","author":"S Alt","year":"2011","unstructured":"Alt S, Mitchenall LA, Maxwell A, Heide L (2011) Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. J Antimicrob Chemother 66:2061\u20132069. https:\/\/doi.org\/10.1093\/jac\/dkr247","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10224_CR55","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.3390\/molecules25122766","volume":"25","author":"HE Hashem","year":"2020","unstructured":"Hashem HE, Amr AE, Nossier ES, Elsayed EA, Azmy EM (2020) Synthesis, antimicrobial activity and molecular docking of novel thiourea derivatives tagged with thiadiazole, imidazole and triazine moieties as potential dna gyrase and topoisomerase iv inhibitors. Molecules 25(12):2766. https:\/\/doi.org\/10.3390\/molecules25122766","journal-title":"Molecules"},{"key":"10224_CR56","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) Swiss ADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"10224_CR57","doi-asserted-by":"publisher","first-page":"104742","DOI":"10.1016\/j.bioorg.2021.104742","volume":"109","author":"EA Fayed","year":"2021","unstructured":"Fayed EA, Bayoumi AH, Saleh AS, Ezz Al-Arab EM, Ammar YA (2021) In vivo and in vitro anti-inflammatory, antipyretic and ulcerogenic activities of pyridone and chromenopyridone derivatives, physicochemical and pharmacokinetic studies. Bioorgan Chem 109:104742. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104742","journal-title":"Bioorgan Chem"},{"key":"10224_CR58","doi-asserted-by":"publisher","first-page":"130159","DOI":"10.1016\/j.molstruc.2021.130159","volume":"1234","author":"EA Fayed","year":"2021","unstructured":"Fayed EA, Ezz Eldin RR, Mehany A, Bayoumi AH, Ammar YA (2021) Isatin-Schiff\u2019s base and chalcone hybrids as chemically apoptotic inducers and EGFR inhibitors; design, synthesis, anti-proliferative activities and in silico evaluation. J Mol Struct 1234:130159. https:\/\/doi.org\/10.1016\/j.molstruc.2021.130159","journal-title":"J Mol Struct"},{"key":"10224_CR59","doi-asserted-by":"publisher","first-page":"130317","DOI":"10.1016\/j.molstruc.2021.130317","volume":"1236","author":"EA Fayed","year":"2021","unstructured":"Fayed EA, Ammar YA, Saleh MA, Bayoumi AH, Belald A, Mehany ABM, Ragab A (2021) Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors. J Mol Struct 1236:130317. https:\/\/doi.org\/10.1016\/j.molstruc.2021.130317","journal-title":"J Mol Struct"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10224-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T18:40:20Z","timestamp":1646073620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10224-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,25]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10224"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10224-4","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,25]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}